An Evaluation of the Usefulness of FDG-PET in Multiple Myeloma

被引：0
|
作者：
Loewenthal, C. P. F. S. [1 ]
Vieira, M. R. [1 ]
LealCosta, F. [1 ]
Parreira, A. [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S94 / S94
页数：1
相关论文
共 50 条
  • [21] FDG-PET in the evaluation of lymphomas
    Bodet-Milin, Caroline
    Salaun, Pierre-Yves
    Crespin, Celine
    Vuillez, Jean-Philippe
    Kraeber-Bodere, Francoise
    HEMATOLOGIE, 2009, 15 (04): : 305 - 312
  • [22] Measuring bone marrow activity with FDG-PET in multiple myeloma, smoldering myeloma, and healthy subjects
    Raynor, William
    Zadeh, Mahdi Zirakchian
    Acosta-Montenegro, Oswaldo
    Khosravi, Mohsen
    Al-Zaghal, Abdullah
    Yellanki, Dani
    Oestergaard, Brian
    Werner, Thomas
    Zhuang, Hongming
    Abildgaard, Niels
    Hoilund-Carlsen, Poul Flemming
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [23] FDG-PET/CT in Multiple Myeloma: Correlation Between SUV and Standard Prognostic Scoring System in Multiple Myeloma
    Ostergaard, B.
    Nielsen, A. L.
    Gerke, O.
    Asmussen, J. T.
    Plesner, T.
    Holdgaard, P.
    Ormstrup, T. E. J.
    Alavi, A.
    Abildgaard, N.
    Hoilund-Carlsen, P. F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S440 - S440
  • [24] Role of FDG-PET/CT in the management of multiple myeloma and plasma cell dyscrasia
    Zhu, Hongyun
    Salavati, Ali
    Goris, Michael
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [25] Use of combined FDG-PET and laboratory data for predicting relapse in multiple myeloma
    Elliott, B. M.
    Peti, S.
    Lee, D.
    Osman, K.
    Isola, L. M.
    Scigliano, E.
    Kostakoglu, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients
    Jamet, Bastien
    Bailly, Clement
    Carlier, Thomas
    Planche, Lucie
    Touzeau, Cyrille
    Kraeber-Bodere, Francoise
    Moreau, Philippe
    Bodet-Milin, Caroline
    LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 222 - 225
  • [27] FDG-PET/CT versus genomic analysis in symptomatic Multiple Myeloma: is there a correlation?
    Bezzi, D.
    Martello, M.
    Terragna, C.
    Zamagni, E.
    Malizia, C.
    Fanti, S.
    Nanni, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S413 - S413
  • [28] Correlation of Dual Time Point FDG-PET with Response to Chemotherapy in Multiple Myeloma
    Taghvaei, Raheleh
    Oestergaard, Brian
    Zadeh, Mahdi Zirakchian
    Raynor, William
    Paydary, Koosha
    Acosta-Montenegro, Oswaldo
    Nielsen, Anne
    Werner, Thomas
    Abildgaard, Niels
    Hoilund-Carlsen, Poul Flemming
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [29] Utility of FDG-PET/CT in detecting extramedullary disease in multiple myeloma patients
    Itskovich, Andrea
    Brown, Tracy
    Barlogie, Bart
    Haessler, Jeff
    Alpe, Terri
    Bartel, Twyla
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [30] Usefulness of FDG-PET in diagnosing primary lymphoma of the liver
    Bangerter, M
    Moog, F
    Griesshammer, M
    Merkle, E
    Hafner, M
    Ellenrieder, V
    Reske, SN
    Heimpel, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1997, 66 (04) : 517 - 520
12345